Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

99.73

-4.25 (-4.09%)

At close: Jan 16, 2026, 4:00 PM EST

97.74

-1.99 (-2.00%)

After-hours: Jan 16, 2026, 5:27 PM EST

Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,180	135	-	-
Enterprise Value	1,133	215	-	-
Last Close Price	99.73	12.00	-	-
PB Ratio	28.59	2.15	-	-
P/TBV Ratio	30.52	2.15	-	-
Debt / Equity Ratio	0.41	0.19	-2.08	-1.40
Quick Ratio	6.38	7.14	3.11	2.78
Current Ratio	6.49	7.33	3.20	2.86
Return on Equity (ROE)	-301.19%	-59.37%	-	-
Return on Assets (ROA)	-47.54%	-18.39%	-61.63%	-
Return on Capital (ROIC)	-63.87%	-22.38%	-110.58%	-
Return on Capital Employed (ROCE)	-55.90%	-18.50%	-228.80%	-167.90%
Earnings Yield	-2.74%	-12.95%	-	-
Buyback Yield / Dilution	-60.51%	-24.08%	68.63%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q